GE HealthCare Technologies (GEHC)
Health Care4 articles
Market Mood
GE Healthcare (GEHC) CFO Purchases $200,585 in Company Stock
James Saccaro, CFO of GE Healthcare (GEHC), purchased $200,585 worth of company stock. This transaction highlights insider confidence in the company’s future performance. Insider buying can be an indication of positive sentiment regarding future stock movements, which may influence investor perception. The purchase took place at a time when GEHC's stock price is subject to market fluctuations, making such insider activity notable for potential investors.
Read More
GEHC Reports Q1 2026 Revenue of $5.1 Billion with 2.9% Growth
GE HealthCare Technologies (GEHC) reported Q1 2026 revenue of $5.1 billion, reflecting a 2.9% organic growth year over year. The company noted a record backlog of $21.8 billion and a book-to-bill ratio of 1.07x. However, management reduced full-year profit guidance due to $250 million in gross inflation and a supplier-related recall, adjusting EPS to between $4.80 and $5.00 while projecting free cash flow of approximately $1.6 billion. Additionally, revenue increased in EMEA and other regions, but U.S. growth experienced mid-single digits, and China revenue improved sequentially despite a year-over-year decline.
Read More
Terri A. Sewell Sells Stake in GE Healthcare (GEHC) and Tapestry (TPR)
Representative Terri A. Sewell reported the sale of stocks in GE Healthcare Technologies (GEHC) and Tapestry (TPR). The disclosed transactions included selling a total of approximately 1,500 shares of GEHC and 3,000 shares of TPR. The sales were registered as part of routine portfolio management. Investor reaction may be influenced by these moves as they could signal a shift in confidence regarding the future performance of these companies.
Read More
GE HealthCare (GEHC) Receives FDA Clearance for Photonova Spectra CT
On March 23, 2026, GE HealthCare Technologies Inc. (GEHC) obtained FDA 510(k) clearance for its Photonova Spectra, a next-generation photon-counting CT system. This system features Deep Silicon detector technology, which provides higher spatial and spectral resolution compared to conventional models. It can process data volumes up to 50 times greater than standard CT systems, supporting efficient workflows. Following this clearance, GEHC is preparing for full commercial availability in the U.S. market, addressing the increasing diagnostic demand.
Read More